94 related articles for article (PubMed ID: 11668486)
21. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q
Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle, environmental, and genetic predictors of bulky DNA adducts in a study population nested within a prospective Danish cohort.
Eriksen KT; Sørensen M; Autrup H; Vogel U; Overvad K; Tjønneland A; Loft S; Raaschou-Nielsen O
J Toxicol Environ Health A; 2010; 73(9):583-95. PubMed ID: 20391138
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
[TBL] [Abstract][Full Text] [Related]
24. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
Brewster AM; Alberg AJ; Strickland PT; Hoffman SC; Helzlsouer K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
[TBL] [Abstract][Full Text] [Related]
25. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
26. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ
Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
28. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.
Benhamou S; Sarasin A
Am J Epidemiol; 2005 Jan; 161(1):1-14. PubMed ID: 15615908
[TBL] [Abstract][Full Text] [Related]
29. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
30. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study.
Matullo G; Peluso M; Polidoro S; Guarrera S; Munnia A; Krogh V; Masala G; Berrino F; Panico S; Tumino R; Vineis P; Palli D
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):674-7. PubMed ID: 12869411
[TBL] [Abstract][Full Text] [Related]
31. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
Hu Z; Wei Q; Wang X; Shen H
Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
[TBL] [Abstract][Full Text] [Related]
32. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
33. Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers.
Godderis L; De Boeck M; Haufroid V; Emmery M; Mateuca R; Gardinal S; Kirsch-Volders M; Veulemans H; Lison D
Environ Mol Mutagen; 2004; 44(4):293-303. PubMed ID: 15468052
[TBL] [Abstract][Full Text] [Related]
34. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
Pavanello S; Siwinska E; Mielzynska D; Clonfero E
Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
[TBL] [Abstract][Full Text] [Related]
35. Influence of DNA repair polymorphisms on biomarkers of genotoxic damage in peripheral lymphocytes of healthy subjects.
Zijno A; Verdina A; Galati R; Leopardi P; Marcon F; Andreoli C; Rossi S; Crebelli R
Mutat Res; 2006 Aug; 600(1-2):184-92. PubMed ID: 16824555
[TBL] [Abstract][Full Text] [Related]
36. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
37. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
[TBL] [Abstract][Full Text] [Related]
38. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.
Yin J; Li J; Ma Y; Guo L; Wang H; Vogel U
Cancer Lett; 2005 Jun; 223(2):219-26. PubMed ID: 15896456
[TBL] [Abstract][Full Text] [Related]
39. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
40. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
